FINWIRES · TerminalLIVE
FINWIRES

HBM Holdings Partner Doses First Patient in SKB378 COPD Study

By

HBM Holdings (HKG:2142) said its partner, Windward Bio, dosed the first patient in a phase II study of SKB378 for chronic obstructive pulmonary disease, according to a Tuesday filing with the Hong Kong bourse.

The drug, also known as HBM9378/WIN378, is also being evaluated in a separate phase II/III asthma study, with initial phase II data expected in the second half of 2026.

The first phase III study of the drug in asthma is expected to begin in the final quarter of 2026.

In a separate filing, HBM Holdings said Chinese regulators accepted the investigational new drug application for HBM7004.

The firm is seeking approval to begin trials of the drug in patients with advanced solid tumors.

Related Articles

Asia

Virgin Australia Launches Flight Search Functionality in ChatGPT

Virgin Australia Holdings (ASX:VGN) launched flight search functionality within the ChatGPT artificial intelligence chatbot, becoming the first airline in Australia to do so, the company said Wednesday.When prompted with travel needs, ChatGPT will direct customers to Virgin Australia flights and Velocity Frequent Flyer Reward Seat options, eliminating the need to navigate multiple website pages, the company said.The launch builds on a collaboration Virgin Australia entered with ChatGPT developer OpenAI in November 2025.

$ASX:VGN
Asia

Posco Holdings Reports One Death in Shinansan Line Accident

Posco Holdings (KRX:005490) disclosed a serious industrial accident at its Shinansan Line l, which left one worker dead, according to a Wednesday filing with the Korea Exchange.The worker fell from a height during electrical work preparation in a vertical shaft on Tuesday. The cause of the fall hasn't been identified yet, the filing said.Police and the Ministry of Employment and Labor are investigating the incident, and accident prevention measures are being written to prevent a recurrence, it said.

$KRX:005490
Asia

BOE Technology Controlling Unit to Withdraw Beijing Listing Application; Shares Fall 8%

BOE Technology (SHE:000725) controlling subsidiary Energy Technology plans to terminate its application for a public issuance of shares and listing on the Beijing Stock ExchangeEnergy Technology cited adjustments to its development strategy and actual operational needs for the move, according to a Wednesday filing with the Shenzhen bourse.The withdrawal is subject to the approval of the subsidiary's shareholders.Shares of the electronics components producer were down nearly 8% in recent trade.

$SHE:000725